Cosmo Bio CompanyLimited Balance Sheet Health
Financial Health criteria checks 6/6
Cosmo Bio CompanyLimited has a total shareholder equity of ¥9.0B and total debt of ¥20.0M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ¥10.9B and ¥1.8B respectively. Cosmo Bio CompanyLimited's EBIT is ¥521.0M making its interest coverage ratio -7.3. It has cash and short-term investments of ¥3.0B.
Key information
0.2%
Debt to equity ratio
JP¥20.00m
Debt
| Interest coverage ratio | -7.3x |
| Cash | JP¥3.03b |
| Equity | JP¥9.02b |
| Total liabilities | JP¥1.85b |
| Total assets | JP¥10.87b |
Recent financial health updates
No updates
Recent updates
Cosmo Bio CompanyLimited (TYO:3386) Is Experiencing Growth In Returns On Capital
May 09
Cosmo Bio Company,Limited (TYO:3386) Vies For A Place In Your Dividend Portfolio: Here's Why
Mar 23Cosmo Bio Company,Limited's (TYO:3386) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 02Will The ROCE Trend At Cosmo Bio CompanyLimited (TYO:3386) Continue?
Feb 07
Does Cosmo Bio CompanyLimited's (TYO:3386) Share Price Gain of 30% Match Its Business Performance?
Jan 17Should Cosmo Bio Company,Limited (TYO:3386) Be Part Of Your Dividend Portfolio?
Dec 23Do Fundamentals Have Any Role To Play In Driving Cosmo Bio Company,Limited's (TYO:3386) Stock Up Recently?
Dec 02Financial Position Analysis
Short Term Liabilities: 3386's short term assets (¥7.1B) exceed its short term liabilities (¥1.1B).
Long Term Liabilities: 3386's short term assets (¥7.1B) exceed its long term liabilities (¥725.0M).
Debt to Equity History and Analysis
Debt Level: 3386 has more cash than its total debt.
Reducing Debt: 3386's debt to equity ratio has reduced from 0.3% to 0.2% over the past 5 years.
Debt Coverage: 3386's debt is well covered by operating cash flow (3680%).
Interest Coverage: 3386 earns more interest than it pays, so coverage of interest payments is not a concern.